TACR1 and pancreatic neoplasm: By activating NK-1R, it can induce tumor-initiating intracellular responses in various cancers, including lung cancer [24], retinoblastoma [25], glioblastomas [26], breast cancer [27], and pancreatic cancer [28], and is correlated with cancer development and progression.